CHICAGO, June 20, 2024 /PRNewswire/ -- The minimally invasive surgical instruments market is projected to grow from USD 31.7 Billion in 2024 to USD 49.9 Billion by 2029, achieving a compound annual growth rate (CAGR) of 9.5%. This expansion is fueled by increasing global surgical procedure volumes, the advantages of minimally invasive techniques compared to traditional surgery, and the growing adoption of advanced robotics in outpatient settings. However, challenges such as evolving regulatory environments and substantial capital investments present significant hurdles to market expansion. Major industry players including Medtronic PLC, Johnson & Johnson, and Intuitive Surgical maintain dominance through expansive global distribution networks and substantial investments in research and development, solidifying their leadership positions in the sector.